Global Blood Therapeutics (GBT)

Global Blood Therapeutics (GBT)

Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities.

Reducing healthcare inequalities: a focus on Sickle Cell Disease Partner Content
28 Jun
Reducing healthcare inequalities: a focus on Sickle Cell Disease
Sebastian Stachowiak, Head of Europe & GCC at Global Blood Therapeutics (GBT), and MEP István Ujhelyi explain how universal screening can help rare disease patients across Europe